Determination of the Optimum Delivery Route for Botulinum Toxin A in Patients With Epiphora

NCT01282541 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

26

Enrollment

INDIV

Sponsor class

Conditions

Epiphora

Interventions

DRUG: Botulinum Toxin Type A
DRUG: Botulinum Toxin Type A

Sponsor

Merbs, Shannath, M.D., Ph.D.